Covered recipient · General Payments record
DOROTHY S ELIZABETH
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,095.00
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $338.38 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $82.59 | 4 |
| Exact Sciences Corporation | $71.07 | 3 |
| Lilly USA, LLC | $41.19 | 3 |
| Janssen Pharmaceuticals, Inc | $25.82 | 1 |
| Biogen, Inc. | $24.19 | 1 |
| Lundbeck LLC | $20.66 | 1 |
| PFIZER INC. | $19.42 | 1 |
| Amgen Inc. | $18.15 | 1 |
| Acerta Pharma LLC | $17.88 | 1 |
| Phathom Pharmaceuticals, Inc. | $17.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.15 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117548023 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.88 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105316138 | CMS |
| Biogen, Inc. | $24.19 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104811703 | CMS |
| Exact Sciences Corporation | $16.05 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114553708 | CMS |
| Exact Sciences Corporation | $26.40 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114553712 | CMS |
| Exact Sciences Corporation | $28.62 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114553716 | CMS |
| Janssen Pharmaceuticals, Inc | $25.82 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078107698 | CMS |
| Lilly USA, LLC | $13.14 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135635090 | CMS |
| Lilly USA, LLC | $14.37 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135574380 | CMS |
| Lilly USA, LLC | $13.68 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135630900 | CMS |
| Lundbeck LLC | $20.66 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146017801 | CMS |
| Novo Nordisk Inc | $18.76 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100608992 | CMS |
| Novo Nordisk Inc | $17.74 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100522151 | CMS |
| Novo Nordisk Inc | $19.37 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100575982 | CMS |
| Novo Nordisk Inc | $26.72 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100371538 | CMS |
| PFIZER INC. | $19.42 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131219068 | CMS |
| Phathom Pharmaceuticals, Inc. | $17.41 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151163212 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.